thalidomide
This page covers all thalidomide drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Tumor necrosis factor.
Targets
Marketed (1)
- Thalomid · Bristol-Myers Squibb · Oncology
Thalomid works by inhibiting the production of tumor necrosis factor, a protein that promotes inflammation and tumor growth.